Lone-star pharma

A researcher at Lexicon Pharmaceuticals Credit: Courtesy of Lexicon Pharmaceuticals" />A researcher at Lexicon Pharmaceuticals Credit: Courtesy of Lexicon Pharmaceuticals Thirty miles north of Houston, texas - and a world away from the biopharmaceutical industry's hubs in California and New Jersey - sits The Woodlands, a sylvan community and home to the headquarters of Lexicon Pharmaceuticals. The compan

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Thirty miles north of Houston, texas - and a world away from the biopharmaceutical industry's hubs in California and New Jersey - sits The Woodlands, a sylvan community and home to the headquarters of Lexicon Pharmaceuticals.

The company was founded in 1995 as Lexicon Genetics, and until last year focused almost exclusively on creating knockout models by the thousands for drug target discovery. This past year, Lexicon shifted gears, moving into the commercial development of drugs. With the organizational change came a new name, Lexicon Pharmaceuticals, soon followed by layoffs of 120 people out of a workforce of about 700 people. Despite the change, Lexicon employees gave their company good marks, winning ninth place in this year's Best Places to Work in Industry overall list, up from 26th place the previous year.

"We all agree that we have a common goal," says Lexicon's associate director of oncology, Rick Finch. "We're ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo